376 related articles for article (PubMed ID: 30195055)
1. Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity.
Zhou Y; Wu J; Sheng R; Li M; Wang Y; Han R; Han F; Chen Z; Qin ZH
Neuroscience; 2018 Nov; 391():140-153. PubMed ID: 30195055
[TBL] [Abstract][Full Text] [Related]
2. NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.
Zhou JS; Zhu Z; Wu F; Zhou Y; Sheng R; Wu JC; Qin ZH
Acta Pharmacol Sin; 2019 Feb; 40(2):180-191. PubMed ID: 29769744
[TBL] [Abstract][Full Text] [Related]
3. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
4. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC
J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
[TBL] [Abstract][Full Text] [Related]
8. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
10. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
[TBL] [Abstract][Full Text] [Related]
11. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
[TBL] [Abstract][Full Text] [Related]
13. EriB targeted inhibition of microglia activity attenuates MPP
Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation.
Hwang CJ; Lee HP; Choi DY; Jeong HS; Kim TH; Lee TH; Kim YM; Moon DB; Park SS; Kim SY; Oh KW; Hwang DY; Han SB; Lee HJ; Hong JT
Oncotarget; 2016 Jul; 7(30):46943-46958. PubMed ID: 27409674
[TBL] [Abstract][Full Text] [Related]
15. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
16. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
[TBL] [Abstract][Full Text] [Related]
17. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
18. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
19. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
20. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
